Effect of multispecies probiotic supplementation on Irritable bowel syndrome

Islamic Azad University0 个研究点目标入组 50 人开始时间: 待定最近更新: 2019年4月23日

适应症

试验速览

暂无简介。

•Patients will be selected based on the Rome II criteria according to the gastroenterologist diagnosis ; (Rome II criteria: abdominal pain or any digestive discomfort for at least 3 months during the last year that can be consecutive or non-consecutive, along with two of the three following items: relieving pain by defecation, starting symptoms associated with change in the frequency of bowel movements, starting symptoms associated with change in the shape of feces)
•Age of at least 18 years old
•The informed consent of the patient, which is submitted in writing form after all necessary explanations are given to him/her.

•History of major gastrointestinal surgery
•chronic use of antibiotics, corticosteroids and immunosuppressive drugs
•Regular use of drugs that alter gastrointestinal movements such as metoclopramide, cisapride, domperidone, narcotics especially opioid derivatives, laxatives, anti-diarrheal agents, as well as other effective drugs for the treatment of IBS, as described in more detail in the text.
•Presence of severe psychological and behavioral disorders in the patient
•Food allergy
•History of any organic bowel disease or chronic digestive illness

发起方